Case review: adult epithelial type Wilms tumor in a 23-year-old female - Report - MDSpire

Case review: adult epithelial type Wilms tumor in a 23-year-old female

  • By

  • Wenchao Cui

  • Yan Wang

  • Fantao Zhang

  • May 13, 2026

  • 0 min

Share

Clinical Report: Epithelial-Type Wilms Tumor in a 23-Year-Old Woman

Overview

{'surgery_details': 'Specify the type of surgical intervention performed.'}

Background

{'histological_subtypes': 'Add details on the clinical implications of different histological subtypes.'}

Data Highlights

{'qualitative_data': 'Include qualitative data or comparisons to enhance the section.'}

Key Findings

{'imaging_results': 'Add relevant imaging results to support the findings.'}

Clinical Implications

{'management_strategies': 'Expand on management strategies and follow-up care.'}

Conclusion

{'histopathological_importance': 'Reiterate the importance of histopathological evaluation.'}

Related Resources & Content

  1. Frontiers in Oncology, 2026 -- BRAF V600E-mutated metastatic Wilms tumor with complete response to targeted RAF/MEK inhibition: a post-treatment follow-up case report
  2. Evaluating the Prognostic Significance of Immunohistochemical Markers in Untreated Wilms' Tumour: Are They Beneficial?, 2011
  3. The ASCO Post, 2015 -- Expert Point of View: Alison M. Friedmann, MD
  4. The ASCO Post, 2015 -- Intensified Therapy Improves Survival in Wilms Tumor Patients With Rare Genetic Abnormality
  5. Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®) - NCI
  6. Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed
  7. Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®) - NCI
  8. Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology - PubMed

Original Source(s)

Case review: adult epithelial type Wilms tumor in a 23-year-old female

  • by Wenchao Cui, Yan Wang, Fantao Zhang

  • May 13, 2026

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report